Stabilizing Lung Function in SSc-ILD May Be Aided With Rituximab:... - Scleroderma News
6/30/2022 12:00:00 AM2 years 10 months ago
by Patricia Inácio, PhD
by Patricia Inácio, PhD
The aim of the study was to see if rituximab stabilized or improved SSc-ILD patients' pulmonary function after 12 months.
The immunosuppressant rituximab may help stabilize lung function in people with systemic sclerosis-related interstitial lung disease (SSc-ILD), a study suggests. The study,Rituximab treatment for sy… [+3290 chars]
full article...